Skip to main content
ELVN logo

Enliven Therapeutics, Inc.

ELVNNASDAQHealthcareBiotechnology

$37.32Today:- (-)1Y +83.70%

As of Oct 16, 2026 close

Market cap
$2.60B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$14.79$62.32
Volume (live)
-
Avg. volume (3M)
1.45M

Enliven Therapeutics, Inc. (ELVN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Enliven Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 13 professional research analysts

Consensus Rating

Buy
Based on 13 unique analysts
(18 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$74.45
+99.49% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ELVN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Phil Nadeau
TD Cowen
BuyMaintains
-
Etzer Darout
Barclays
BuyMaintains
$78.00
Andy Hsieh
William Blair
BuyReiterates
-
Sean Laaman
Morgan Stanley
BuyReiterates
$70.00
Priyanka Grover
JP Morgan
BuyInitiates
$75.00
Andy Hsieh
William Blair
BuyMaintains
-
Etzer Darout
Barclays
BuyInitiates
$78.00
Salim Syed
Mizuho
BuyMaintains
$62.00 → $73.00
Dara Azar
Stifel Nicolaus
BuyReiterates
$82.00
Sam Slutsky
LifeSci Capital
BuyInitiates Coverage
$60.00 → $70.00
Sam Slutsky
LifeSci Capital
BuyReiterates
$60.00 → $70.00
Kaveri Pohlman
Clear Street
BuyInitiates Coverage
$55.00 → $68.00
Michael Schmidt
Guggenheim
BuyMaintains
$80.00 → $78.00
Boris Peaker
JonesTrading
BuyReiterates
$70.00
Colleen M. Kusy
Baird
BuyMaintains
$60.00 → $75.00
Michael Schmidt
Guggenheim
BuyMaintains
$80.00 → $78.00
Phil Nadeau
TD Cowen
BuyMaintains
-
Salveen Richter
Goldman Sachs
BuyInitiates Coverage
$67.00 → $80.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 8, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ELVN?

The analyst consensus rating for ELVN is Buy, based on the latest ratings from 13 analysts over the last 90 days.

What is the average price target for ELVN?

The average 12-month price target for ELVN is $74.45, representing an upside of 99.5% from the Oct 16, 2026 close of $37.32.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.